Vaccine News and Research

Latest Vaccine News and Research

Project NextGen awards over $1.4 billion to develop the future of COVID-19 vaccines and therapeutics

Funding includes $1 billion for vaccine clinical trials, $326 million for a new monoclonal antibody, and $100 million to explore novel vaccine and therapeutic technologies.

23 Aug 2023

Study explores lipid and metabolic alterations in HIV/TB co-infected patients

Researchers investigated the differential impact of HIV/tuberculosis co-infection on lipid and metabolic profiles.

23 Aug 2023

Current and future strategies for vaccinating against invasive pneumococcal disease

Researchers reviewed the immune mechanisms employed by existing vaccines for invasive pneumococcal disease.

23 Aug 2023

High-fat diet changes gut bacteria, bile acids, and increases colorectal cancer risk

The prevalence of colorectal cancer in people under the age of 50 has risen in recent decades. One suspected reason: the increasing rate of obesity and high-fat diets.

22 Aug 2023

Malaria vaccine and drug combination reduces hospitalizations, deaths in children

The final results of a landmark study published in The Lancet Infectious Diseases confirm that the benefits of combining the RTS,S/AS01E (RTS,S) malaria vaccine with antimalarial drugs in settings of highly seasonal malaria transmission continue over five years.

22 Aug 2023

Many older adults show interest in getting vaccinated against respiratory syncytial virus

The first Americans over age 60 just started rolling up their sleeves to get vaccinated against respiratory syncytial virus, or RSV, now that brand-new vaccines have started to arrive at pharmacies and clinics.

22 Aug 2023

Strep A infections on the rise among Australians, study finds

Australia has experienced an intense surge in severe Strep A cases, similar to the northern hemisphere wave, despite differences in seasons and circulating respiratory viruses, according to a new study.

22 Aug 2023

Few firm beliefs and low trust: Americans not sure what’s true in age of health misinformation

Around 3 in 10 Americans still believe ivermectin is an effective treatment for covid. What's more, few place significant trust in any form of news media or official institution to accurately convey information about health topics, from covid treatments and vaccines to reproductive health issues, a new poll from KFF shows.

22 Aug 2023

Omicron infection may increase risk of reinfection, study finds

Researchers at McMaster University have found that rather than conferring immunity against future infections, infection during the first Omicron wave of COVID left the seniors they studied much more vulnerable to reinfection during the second Omicron wave.

21 Aug 2023

Cancer patients may need more frequent COVID-19 booster shots, study finds

For many, the threat of the COVID-19 pandemic seems over. However, for patients whose immune systems are compromised by cancer or by cancer therapies, fear of COVID-19 infection and severe disease remains very real.

21 Aug 2023

COVID-19 vaccination in low- and middle-income countries should complement routine childhood vaccines

COVID-19 vaccines are effective against severe cases of the disease in children and adolescents, according to a review.

21 Aug 2023

COVID-19 infection linked to increased risk of high blood pressure

An analysis of electronic medical records for more than 45,000 people found that COVID-19 infection was significantly associated with the development of high blood pressure, according to new research published today in Hypertension, an American Heart Association journal.

21 Aug 2023

COVID-19 associated with increased risk of developing various autoimmune diseases and risk could be attenuated by vaccination

COVID-19 can increase the risk of various autoimmune diseases; however, this risk appears to be mitigated by vaccination against COVID-19.

21 Aug 2023

Glycans and GBPs: How their interplay shapes immunity in infection and autoimmune diseases

Researchers discuss the regulatory roles of glycans and glycan-binding proteins in modulating immune responses.

21 Aug 2023

New technique cuts polio detection time in half

New research supported by the Medicines and Healthcare products Regulatory Agency (MHRA) has shown that the time to detect polio can be halved using a technique called Direct molecular Detection and Nanopore Sequencing (DDNS), supporting the global effort to eradicate polio and help save lives.

21 Aug 2023

Common cold coronaviruses may offer pre-existing immunity to COVID-19

Exposure to common cold-causing coronaviruses may contribute to pre-existing immunity to COVID-19, according to a new study involving a Rutgers research scientist.

18 Aug 2023

Vaccination reduces risk of severe COVID-19 in solid organ transplant recipients

Findings from a two-year study of nearly 2,400 solid organ transplant recipients, conducted by the Johns Hopkins Transplant Research Center (TRC) in collaboration with the New York University Center for Surgical and Applied Transplant Research, indicate spikes of post-vaccination SARS-CoV-2 viral infections (commonly known as COVID-19 breakthrough cases) remain common, yet hospitalization rates have dramatically dropped following the first wave of the virus' omicron subvariant.

18 Aug 2023

Scientists urge vaccination funding as Ghana and Nigeria grapple with anthrax outbreaks

As Ghana and Nigeria grapple with outbreaks of anthrax, scientists say governments must prioritize funds for vaccination to prevent a re-emergence of the disease across West Africa.

18 Aug 2023

DDNS technique could reduce the time to detect polio, study shows

A new study, 'Sensitive poliovirus detection using nested PCR and nanopore sequencing: a prospective validation study', published today (17 August 2023) in Nature Microbiology, proves that using DDNS to detect polio outbreaks can save public health authorities crucial time and money.

18 Aug 2023

Host viral burden increases with age, is reduced by vaccination, and is influenced by vaccination status and viral variant interplay

The impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants on host viral burden.

18 Aug 2023

Previous
1
...
60
61
62
63
64
65
66
...
1122
Next

Vaccine News and Research

Latest Vaccine News and Research

Project NextGen awards over $1.4 billion to develop the future of COVID-19 vaccines and therapeutics

Study explores lipid and metabolic alterations in HIV/TB co-infected patients

Current and future strategies for vaccinating against invasive pneumococcal disease

High-fat diet changes gut bacteria, bile acids, and increases colorectal cancer risk

Malaria vaccine and drug combination reduces hospitalizations, deaths in children

Many older adults show interest in getting vaccinated against respiratory syncytial virus

Strep A infections on the rise among Australians, study finds

Few firm beliefs and low trust: Americans not sure what’s true in age of health misinformation

Omicron infection may increase risk of reinfection, study finds

Cancer patients may need more frequent COVID-19 booster shots, study finds

COVID-19 vaccination in low- and middle-income countries should complement routine childhood vaccines

COVID-19 infection linked to increased risk of high blood pressure

COVID-19 associated with increased risk of developing various autoimmune diseases and risk could be attenuated by vaccination

Glycans and GBPs: How their interplay shapes immunity in infection and autoimmune diseases

New technique cuts polio detection time in half

Common cold coronaviruses may offer pre-existing immunity to COVID-19

Vaccination reduces risk of severe COVID-19 in solid organ transplant recipients

Scientists urge vaccination funding as Ghana and Nigeria grapple with anthrax outbreaks

DDNS technique could reduce the time to detect polio, study shows

Host viral burden increases with age, is reduced by vaccination, and is influenced by vaccination status and viral variant interplay

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Vaccine News and Research

Latest Vaccine News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in